What Is CJC-1295? Overview of Laboratory Research Applications

CJC-1295 research peptide vial with molecular structure illustration in a laboratory research setting

Introduction

CJC-1295 is a synthetic research peptide commonly referenced in laboratory and preclinical research settings. It is studied for its structural properties and its role in experimental biological models related to signalling pathways.

This article provides an educational overview of CJC-1295, focusing on its chemical characteristics, how it is described in scientific literature, and the general areas in which it is explored within controlled research environments.

For a broader understanding of how synthetic peptides are used in controlled environments, see our guide on Research Peptides Explained: Quality, Purpose & Responsible Use.

What Is CJC-1295?

CJC-1295 is a synthetic peptide analogue developed for research purposes. It is structurally related to growth hormone–releasing hormone (GHRH) and is designed to interact with specific receptors in experimental models.

In scientific literature, CJC-1295 is often discussed in the context of laboratory research examining hormonal signalling mechanisms and peptide-receptor interactions.

CJC-1295 (No Dac) is available as a research peptide here.

Chemical Structure and Characteristics

CJC-1295 consists of a modified peptide sequence designed to enhance stability in laboratory conditions. These structural modifications are commonly referenced in research discussions related to:

  • Peptide binding affinity in experimental systems

  • Resistance to enzymatic degradation in vitro

  • Prolonged activity profiles within controlled research models

As with all research peptides, CJC-1295 is synthesised strictly for non-human, non-clinical laboratory research use.

More information on synthesis methods and laboratory verification can be found in our article on How Research Peptides Are Manufactured and Tested for Quality.

Areas of Scientific Research Interest

Within laboratory and preclinical research settings, CJC-1295 is commonly referenced in studies exploring:

  • Hormonal signalling pathways

  • Cellular communication mechanisms

  • Peptide stability and receptor interaction models

All research involving CJC-1295 is conducted in controlled environments and does not involve approved medical or therapeutic use.

Handling and Storage in Research Settings

To maintain peptide integrity and research consistency, CJC-1295 is typically handled according to standard laboratory protocols, which may include:

  • Refrigerated or frozen storage conditions

  • Protection from light and moisture

  • Careful handling during preparation and experimentation

Proper storage and handling support reliable outcomes in scientific research applications.

For detailed best practices, see Peptide Stability, Storage, and Handling in Research Settings.

Legal and Regulatory Considerations in the UK

In the UK, CJC-1295 is supplied strictly as a research chemical. It is not authorised as a medicinal product and must not be marketed for human or veterinary use.

Responsible suppliers ensure clear labelling, accurate product descriptions, and compliance with UK regulations governing research chemicals and laboratory materials.

A more comprehensive overview of compliance requirements is available in The Legal and Regulatory Status of Research Peptides in the UK.

Summary

CJC-1295 is a synthetic research peptide studied in laboratory settings for its structural properties and role in experimental signalling models. Educational discussions surrounding CJC-1295 focus on its chemistry, research context, and regulatory classification.

As with all research peptides, its use is limited to qualified professionals operating within controlled laboratory environments.

For researchers examining multiple compounds together see our CJC-1295 & Ipamorelin Research Set


Related Research Peptide Guides

Links: